EODData

MEMBERSHIP REGISTER LOG IN

ASX, PER: Percheron Therapeutics Ltd.

04 Sep 2026
LAST:

0.0050

CHANGE:
 0.00		OPEN:
0.0050		HIGH:
0.0050		ASK:
0.0110		VOLUME:
194.6K
CHG(%):
0.00		PREV:
0.0050		LOW:
0.0050		BID:
0.0100		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 260.00500.00500.00500.0050194.6K
03 Sep 260.00500.00500.00500.005053.6K
02 Sep 260.00500.00500.00500.00506.3M
01 Sep 260.00600.00600.00500.005012.41M
31 Aug 260.00500.00500.00500.00500
28 Aug 260.00500.00500.00500.00500
27 Aug 260.00500.00500.00500.00501.33M
26 Aug 260.00500.00500.00450.00502.8M
25 Aug 260.00500.00500.00500.00502.0K
24 Aug 260.00500.00600.00500.005013.53M

PROFILE

Name:Percheron Therapeutics Ltd.
About:Percheron Therapeutics Limited engages in the research and development of novel antisense pharmaceuticals for cancer and rare diseases in Australia. The company's lead asset is ATL1102, an antisense oligonucleotide inhibitor of CD49d, which is in Phase IIb clinical trial for the treatment of Duchenne muscular dystrophy, multiple sclerosis, asthma, and other inflammatory indications. It also develops HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed Phase I clinical trial to targer v-domain immunoglobulin suppressor of T-cell activation and cancer cells. The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is headquartered in Melbourne, Australia.
Sector:Healthcare
Address:Collins Place, Melbourne, VIC, Australia, 3000
Website:https://percherontx.com
ISIN:AU000000ANP4
FIGI:BBG000BCF0F7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.35 
Forward P/E:-1.06 
PEG Ratio:-1.06 
Price to Sales:9.02 
Price to Book:0.83 
Operating Margin:-2.23 
Return on Assets:-0.29 
Return on Equity:-0.55 
EPS Ratio:-0.01 
Revenue:843.6K 
Shares:1.522B 
Market Cap:7.61M 

TECHNICAL INDICATORS

MA5:0.010.0%
MA10:0.010.0%
MA20:0.004.2%
MA50:0.0031.6%
MA100:0.0022.0%
MA200:0.0114.0%
RSI14:50.00
WPR14:-100.00 
ATR:0.00 
Week High:0.0120.0%
Week Low:0.010.0%
Month High:0.0120.0%
Month Low:0.0014.0%
Year High:0.01120.0%
Year Low:0.00150.0%
Volatility:140.57 

RECENT SPLITS

Date Ratio
05 Nov 20131-10